Application of 5-bromocytidine in preparation of medicine or health care product for treating hyperuricemia

What is AI technical title?
AI technical title is built by Patsnap AI team. It summarizes the technical point description of the patent document.
By preparing 5-bromocytidine into different dosage forms for the treatment of hyperuricemia, the problem of major side effects of existing drugs has been solved, and the effect of significantly reducing serum uric acid and reducing gout complications is achieved.

CN120284994APending Publication Date: 2025-07-11LANZHOU UNIV

0 Cites 1 Cited by

Patent Information

Application Number: CN202410031861.X
Authority / Receiving Office: CN · China
Patent Type: Applications(China)
Current Assignee / Owner
Filing Date: 2024-01-09
Publication Date: 2025-07-11

Application Information

Patent Timeline

09 Jan 2024

Application

CN202410031861.X

11 Jul 2025

Publication

CN120284994A

IPC: A61K31/7068; A23L33/10; A61P19/06; A61P13/12

CPC: A61K31/7068; A61P19/06; A61P13/12; A23L33/10; A23V2002/00; A23V2200/30

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

AI Tagging

Application Domain

Organic active ingredients Skeletal disorder

Technology Topics

Pharmacy medicine Pharmaceutical drug

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

AI Technical Summary

Technical Problem

The existing hyperuricemia treatment drugs have great side effects, and it is urgent to develop therapeutic drugs and health products with low side effects.

Method used

5-bromocytidine is used as a pharmaceutically acceptable carrier to prepare it into different dosage forms for the treatment of hyperuricemia, including powders, tablets, capsules, etc., and is used by sublingual ingestion or swallowing, for acute or chronic gout and related complications, such as gout arthritis, gouty nephropathy, etc.

Benefits of technology

5-bromocytidine significantly reduces the uric acid content in the serum, has the function of treating hyperuricemia, reduces the risk of uric acid crystal formation in the blood, and reduces the occurrence of complications such as gout.

✦ Generated by Eureka AI based on patent content.

Patent Text Reader

Abstract

The invention relates to the technical field of medicine, in particular to application of 5-bromocytidine in medicine for treating hyperuricemia, the 5-bromocytidine can effectively reduce the content of uric acid in serum, namely, the 5-bromocytidine has the effect of treating the hyperuricemia.

Need to check novelty before this filing date? Find Prior Art